VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 147 filers reported holding VIKING THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.76 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,060,661 | -42.3% | 95,814 | -15.5% | 0.00% | -50.0% |
| Q2 2023 | $1,838,603 | +106.1% | 113,424 | +111.7% | 0.00% | +100.0% |
| Q1 2023 | $892,057 | – | 53,577 | +148725.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 36 | -99.9% | 0.00% | – |
| Q1 2022 | $148,000 | -35.9% | 49,134 | -2.4% | 0.00% | – |
| Q4 2021 | $231,000 | -17.2% | 50,362 | +13.5% | 0.00% | – |
| Q3 2021 | $279,000 | +17.7% | 44,370 | +12.1% | 0.00% | – |
| Q2 2021 | $237,000 | -42.6% | 39,587 | -39.2% | 0.00% | – |
| Q1 2021 | $413,000 | -51.4% | 65,153 | -56.8% | 0.00% | – |
| Q4 2020 | $849,000 | -32.8% | 150,923 | -30.5% | 0.00% | -100.0% |
| Q3 2020 | $1,263,000 | -6.7% | 217,032 | +15.5% | 0.00% | 0.0% |
| Q2 2020 | $1,354,000 | +131.5% | 187,909 | +50.1% | 0.00% | 0.0% |
| Q1 2020 | $585,000 | -47.8% | 125,219 | -10.4% | 0.00% | 0.0% |
| Q4 2019 | $1,120,000 | +314.8% | 139,696 | +255.1% | 0.00% | – |
| Q3 2019 | $270,000 | -5.6% | 39,340 | +14.1% | 0.00% | – |
| Q2 2019 | $286,000 | -24.3% | 34,471 | -9.3% | 0.00% | – |
| Q1 2019 | $378,000 | +62.2% | 38,025 | +25.2% | 0.00% | – |
| Q4 2018 | $233,000 | -71.6% | 30,365 | -64.9% | 0.00% | -100.0% |
| Q2 2018 | $821,000 | – | 86,488 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| APIS CAPITAL ADVISORS, LLC | 148,000 | $1,638,360 | 2.12% |
| Sio Capital Management, LLC | 595,002 | $6,586,672 | 2.04% |
| 5AM Venture Management, LLC | 585,000 | $6,475,950 | 1.86% |
| Artia Global Partners LP | 383,580 | $4,246,231 | 1.76% |
| Integral Health Asset Management, LLC | 800,000 | $8,856,000 | 1.23% |
| Boxer Capital, LLC | 2,000,000 | $22,140,000 | 1.18% |
| DAFNA Capital Management LLC | 319,655 | $3,538,581 | 1.10% |
| Affinity Asset Advisors, LLC | 332,600 | $3,681,882 | 1.04% |
| MPM BioImpact LLC | 325,000 | $3,597,750 | 0.96% |
| Affinity Asset Advisors, LLC | 300,000 | $3,321,000 | 0.93% |